Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study

BACKGROUND: Post-authorisation vaccine safety surveillance is well established for reporting common adverse events of interest (AEIs) following influenza vaccines, but not for COVID-19 vaccines. AIM: To estimate the incidence of AEIs presenting to primary care following COVID-19 vaccination in Engla...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsang, Ruby SM, Joy, Mark, Byford, Rachel, Robertson, Chris, Anand, Sneha N, Hinton, William, Mayor, Nikhil, Kar, Debasish, Williams, John, Victor, William, Akbari, Ashley, Bradley, Declan T, Murphy, Siobhan, O’Reilly, Dermot, Owen, Rhiannon K, Chuter, Antony, Beggs, Jillian, Howsam, Gary, Sheikh, Aziz, Hobbs, FD Richard, de Lusignan, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853944/
https://www.ncbi.nlm.nih.gov/pubmed/36695484
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.3.2200195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853944/
https://www.ncbi.nlm.nih.gov/pubmed/36695484
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.3.2200195

Ejemplares similares